176 related articles for article (PubMed ID: 22558341)
21. Targeted conjugation of breast anticancer drug tamoxifen and its metabolites with synthetic polymers.
Sanyakamdhorn S; Agudelo D; Bekale L; Tajmir-Riahi HA
Colloids Surf B Biointerfaces; 2016 Sep; 145():55-63. PubMed ID: 27137803
[TBL] [Abstract][Full Text] [Related]
22. Review on the targeted conjugation of anticancer drugs doxorubicin and tamoxifen with synthetic polymers for drug delivery.
Sanyakamdhorn S; Agudelo D; Tajmir-Riahi HA
J Biomol Struct Dyn; 2017 Aug; 35(11):2497-2508. PubMed ID: 27598545
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
24. Binding analysis of antioxidant polyphenols with PAMAM nanoparticles.
Chanphai P; Tajmir-Riahi HA
J Biomol Struct Dyn; 2018 Oct; 36(13):3487-3495. PubMed ID: 29019428
[TBL] [Abstract][Full Text] [Related]
25. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
26. Structural analysis of doxorubicin-polymer conjugates.
Sanyakamdhorn S; Bekale L; Agudelo D; Tajmir-Riahi HA
Colloids Surf B Biointerfaces; 2015 Nov; 135():175-182. PubMed ID: 26255162
[TBL] [Abstract][Full Text] [Related]
27. mPEG-PAMAM-G4 nucleic acid nanocomplexes: enhanced stability, RNase protection, and activity of splice switching oligomer and poly I:C RNA.
Reyes-Reveles J; Sedaghat-Herati R; Gilley DR; Schaeffer AM; Ghosh KC; Greene TD; Gann HE; Dowler WA; Kramer S; Dean JM; Delong RK
Biomacromolecules; 2013 Nov; 14(11):4108-15. PubMed ID: 24164501
[TBL] [Abstract][Full Text] [Related]
28. Binding efficacy of tRNA with folic acid-PAMAM nanoparticles.
Chanphai P; Tajmir-Riahi HA
Int J Biol Macromol; 2018 Jul; 114():851-854. PubMed ID: 29621502
[TBL] [Abstract][Full Text] [Related]
29. Atomic level insights into realistic molecular models of dendrimer-drug complexes through MD simulations.
Jain V; Maiti PK; Bharatam PV
J Chem Phys; 2016 Sep; 145(12):124902. PubMed ID: 27782646
[TBL] [Abstract][Full Text] [Related]
30. DNA compaction by a dendrimer.
Nandy B; Maiti PK
J Phys Chem B; 2011 Jan; 115(2):217-30. PubMed ID: 21171620
[TBL] [Abstract][Full Text] [Related]
31. Targeting Breast Cancer Cells with G4 PAMAM Dendrimers and Valproic Acid Derivative Complexes.
Muñoz AM; Fragoso-Vázquez MJ; Martel BP; Chávez-Blanco A; Dueñas-González A; R García-Sánchez J; Bello M; Romero-Castro A; Correa-Basurto J
Anticancer Agents Med Chem; 2020; 20(15):1857-1872. PubMed ID: 32324521
[TBL] [Abstract][Full Text] [Related]
32. Complex formation between endogenous toxin bilirubin and polyamidoamine dendrimers: a spectroscopic study.
Shcharbin D; Bryszewska M
Biochim Biophys Acta; 2006 Jul; 1760(7):1021-6. PubMed ID: 16716522
[TBL] [Abstract][Full Text] [Related]
33. Conjugation of steroids with PAMAM nanoparticles.
Chanphai P; Bekale L; Tajmir-Riahi HA
Colloids Surf B Biointerfaces; 2015 Dec; 136():1035-41. PubMed ID: 26590896
[TBL] [Abstract][Full Text] [Related]
34. Spectroscopic and molecular modeling studies of the interaction between morin and polyamidoamine dendrimer.
Zhang H; Cao J; Wang Y
Luminescence; 2014 Sep; 29(6):573-8. PubMed ID: 24108475
[TBL] [Abstract][Full Text] [Related]
35. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
36. Spectroscopic and calorimetric studies on the interaction between PAMAM G4-OH and 5-fluorouracil in aqueous solutions.
Buczkowski A; Urbaniak P; Piekarski H; Palecz B
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jan; 171():401-405. PubMed ID: 27569773
[TBL] [Abstract][Full Text] [Related]
37. Poly(amidoamine) dendrimers as skin penetration enhancers: Influence of charge, generation, and concentration.
Venuganti VV; Perumal OP
J Pharm Sci; 2009 Jul; 98(7):2345-56. PubMed ID: 18937369
[TBL] [Abstract][Full Text] [Related]
38. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
[TBL] [Abstract][Full Text] [Related]
39. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin.
Ciolkowski M; Rozanek M; Bryszewska M; Klajnert B
Biochim Biophys Acta; 2013 Oct; 1834(10):1982-7. PubMed ID: 23851144
[TBL] [Abstract][Full Text] [Related]
40. Interaction of polyamidoamine (PAMAM) succinamic acid dendrimers generation 4 with human serum albumin.
Sekowski S; Buczkowski A; Palecz B; Gabryelak T
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Oct; 81(1):706-10. PubMed ID: 21788153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
